X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (132) 132
index medicus (130) 130
humans (124) 124
male (98) 98
female (92) 92
middle aged (80) 80
aged (72) 72
echocardiography (42) 42
cardiovascular (41) 41
risk factors (37) 37
abridged index medicus (36) 36
treatment outcome (33) 33
atrial fibrillation (32) 32
heart failure (31) 31
mortality (31) 31
stroke (30) 30
adult (28) 28
medical and health sciences (25) 25
medicin och hälsovetenskap (25) 25
peripheral vascular disease (24) 24
anticoagulants (22) 22
drug therapy (22) 22
warfarin (22) 22
analysis (20) 20
clinical medicine (20) 20
double-blind method (20) 20
cardiac arrhythmia (19) 19
cardiology (19) 19
stroke - prevention & control (19) 19
hypertension (18) 18
klinisk medicin (18) 18
prospective studies (18) 18
radiology, nuclear medicine & medical imaging (18) 18
risk (18) 18
aspirin (17) 17
heart attacks (17) 17
heart-failure (17) 17
internal medicine (17) 17
reference values (17) 17
cardiovascular disease (16) 16
follow-up studies (16) 16
reproducibility of results (16) 16
therapy (16) 16
heart (15) 15
aged, 80 and over (14) 14
atherosclerosis (14) 14
atrial fibrillation - drug therapy (14) 14
cardiac and cardiovascular systems (14) 14
care and treatment (14) 14
clinical trials (14) 14
echocardiography - methods (14) 14
electrocardiography (14) 14
guidelines (14) 14
heart ventricles - diagnostic imaging (14) 14
kardiologi (14) 14
management (14) 14
myocardial infarction (14) 14
patients (14) 14
prevention (14) 14
apixaban (13) 13
cardiovascular diseases (13) 13
ventricular function, left - physiology (13) 13
acute coronary syndromes (12) 12
coronary heart disease (12) 12
drug therapy, combination (12) 12
medicine, general & internal (12) 12
time factors (12) 12
ventricular dysfunction, left - diagnostic imaging (12) 12
disease (11) 11
fibrillation (11) 11
life sciences (11) 11
patient outcomes (11) 11
prognosis (11) 11
risk assessment (11) 11
usage (11) 11
bleeding (10) 10
cardiac patients (10) 10
coronary artery disease (10) 10
europe (10) 10
health aspects (10) 10
hemorrhage - chemically induced (10) 10
myocardial-infarction (10) 10
observer variation (10) 10
recommendations (10) 10
ventricular dysfunction, left - physiopathology (10) 10
age factors (9) 9
anticoagulants - therapeutic use (9) 9
atrial fibrillation - complications (9) 9
comparative analysis (9) 9
diabetes (9) 9
european association (9) 9
healthy volunteers (9) 9
heart diseases (9) 9
hospitalization (9) 9
medical research (9) 9
mitral valve insufficiency - diagnostic imaging (9) 9
outcomes (9) 9
registries (9) 9
sex factors (9) 9
strain (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Therapeutics, ISSN 1075-2765, 2017, Volume 24, Issue 2, pp. e109 - e110
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9855, pp. 1749 - 1758
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 8, pp. 699 - 708
In a randomized trial, patients with an acute coronary syndrome were assigned to receive apixaban or placebo in addition to standard therapy. The apixaban... 
ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | HIGH-RISK PATIENTS | CLOPIDOGREL | MYOCARDIAL-INFARCTION | WARFARIN | DOUBLE-BLIND | THROMBOPROPHYLAXIS | ASPIRIN | INTERVENTION | FACTOR XA INHIBITOR | Myocardial Infarction - epidemiology | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Aspirin - adverse effects | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyrazoles - adverse effects | Stroke - prevention & control | Double-Blind Method | Angina, Unstable - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Acute Coronary Syndrome - drug therapy | Angina, Unstable - prevention & control | Aged | Myocardial Infarction - prevention & control | Pyridones - therapeutic use | Hemorrhage - chemically induced | Pyridones - adverse effects | Myocardial infarction | Cerebral infarction | Anticoagulants | Stroke | Aspirin | Heart attacks | Statistical analysis | Risk groups | Clinical trials | Angina pectoris | Thrombosis | Bone surgery | Thrombolysis | Bleeding | Risk factors | Studies | Disease prevention | Ischemia | Acute coronary syndromes | Health risk assessment | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article